Correction: All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation
Abstract
Correction for ‘All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation’ by Xiao-xiao Guo et al., Nanoscale, 2021, 13, 14525–14537, https://doi.org/10.1039/D1NR03869A.